White matter hyperintensities and depression—preliminary results from the LADIS study
✍ Scribed by Michael J. Firbank; John T. O'Brien; Sanjeet Pakrasi; Leonardo Pantoni; Michela Simoni; Timo Erkinjuntti; Anders Wallin; Lars-Olof Wahlund; Ilse van Straaten; Domenico Inzitari
- Book ID
- 102226901
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 69 KB
- Volume
- 20
- Category
- Article
- ISSN
- 0885-6230
- DOI
- 10.1002/gps.1342
No coin nor oath required. For personal study only.
✦ Synopsis
Background White matter hyperintensities have been associated with the development of depression in older subjects, though the details of this relationship are not fully understood. Methods In a pan-European multicentre study of 629 older subjects, we examined the relationship between MRI white matter hyperintensities (WMH), depressive symptoms and self perceived health quality of life (QOL). WMH were rated using a three-point scale.
Results We found depressive symptoms as assessed by the geriatric depression 15-item scale to be associated with WMH rating (Spearman's rho 0.11, p ¼ 0.008) and also with the Euro-QOL health score (Spearman's rho À0.5, p < 0.001). In a ordinal logistic regression model, QOL was found to strongly predict GDS score (p < 0.001) and severe vs mild WMH were associated with increased depression (p ¼ 0.028). The relationship between history of severe depression and WMH score was examined, but there were no differences either between those with and without a history of severe depression, or those with an early vs late onset of depression. Conclusions The results suggest that WMH play a role in increasing depressive symptoms, even when perceived quality of life is controlled for as a possible mediating factor.
📜 SIMILAR VOLUMES
## Background: Cerebrovascular disease is thought to play a role in the pathogenesis of geriatric major depression. one finding supporting such a "vascular depression" is the increased neuropathology in the form of white matter hyperintensities (wmh) found in patients diagnosed with a late-onset de